
|Articles|November 15, 2013
- NSCLC (Issue 1)
- Volume 1
- Issue 1
Guidelines for Molecular Testing in Lung Cancer
Author(s)Mark G. Kris, MD
Mark G. Kris, MD, William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan-Kettering Cancer Center, gives an overview of current guidelines for molecular testing in lung cancer.
Advertisement
Mark G. Kris, MD, William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan-Kettering Cancer Center, gives an overview of current guidelines for molecular testing in lung cancer.
Read more about
Articles in this issue
about 12 years ago
Molecular Targeted Agents for Stage III NSCLCabout 12 years ago
Molecular Targets in Non-Small Cell Lung Cancerabout 12 years ago
Multidisciplinary Perspectives: Molecular Testing in NSCLCabout 12 years ago
World Conference on Lung Cancer 2013 Highlightsabout 12 years ago
The Treatment of Lung Cancer Subgroupsabout 12 years ago
Treating Squamous vs Nonsquamous DiseaseAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































